| Year |
Citation |
Score |
| 2021 |
Jeong IG, Lim B, Yun SC, Lim JH, Hong JH, Kim CS. Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34011557 DOI: 10.1158/1078-0432.CCR-21-0480 |
0.349 |
|
| 2021 |
Lim B, Lee W, Kyung YS, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer. Journal of Cancer Research and Clinical Oncology. PMID 33948720 DOI: 10.1007/s00432-021-03642-2 |
0.335 |
|
| 2021 |
An DH, Kim H, Lee D, Jeong IG, You D, Hong JH, Kim C, Ahn H. Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide The Korean Journal of Urological Oncology. 19: 60-69. DOI: 10.22465/KJUO.2021.19.1.60 |
0.315 |
|
| 2020 |
Pak S, You D, Jeong IG, Lee DE, Kim SH, Joung JY, Lee KH, Hong JH, Kim CS, Ahn H. Cause of Mortality After Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-Institutional Study in Korea. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 32632083 DOI: 10.4143/crt.2020.286 |
0.318 |
|
| 2020 |
Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, ... Hong JH, et al. Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting. Investigative and Clinical Urology. 61: 19-27. PMID 31942459 DOI: 10.4111/icu.2020.61.1.19 |
0.322 |
|
| 2020 |
Lee SJ, Yu SH, Kim Y, Kim JK, Hong JH, Kim C, Seo SI, Byun S, Jeong CW, Lee JY, Choi IY. Prediction System for Prostate Cancer Recurrence Using Machine Learning Applied Sciences. 10: 1333. DOI: 10.3390/app10041333 |
0.348 |
|
| 2019 |
Kim H, Pak S, Park KJ, Kim MH, Kim JK, Kim M, You D, Jeong IG, Song C, Hong JH, Kim CS, Ahn H. Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease? Clinical Genitourinary Cancer. PMID 31640913 DOI: 10.1016/j.clgc.2019.09.018 |
0.345 |
|
| 2019 |
Lee SJ, Yu SH, Kim Y, Hong JH, Kim CS, Seo SI, Jeong CW, Byun SS, Chung BH, Lee JY, Choi IY. Development of Integrated Data and Prediction System Platform for the Localized Prostate Cancer. Studies in Health Technology and Informatics. 264: 1506-1507. PMID 31438204 DOI: 10.3233/SHTI190507 |
0.351 |
|
| 2019 |
Pak S, You D, Jeong IG, Kim YS, Hong JH, Kim CS, Ahn H. Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer. International Journal of Clinical Oncology. PMID 31087170 DOI: 10.1007/s10147-019-01463-5 |
0.364 |
|
| 2019 |
Yu SH, Choi MJ, Lee SJ, Kim CS, Seo SI, Byun SS, Jeong CW, Park YH, Hong JH, Choi IY. Biochemical Recurrence Prediction after Radical Prostatectomy Using Korean Prostate Cancer Registry Database Journal of Health Informatics and Statistics. 44: 53-63. DOI: 10.21032/JHIS.2019.44.1.53 |
0.34 |
|
| 2019 |
Young Choi S, Lim B, Han JH, Kyung YS, An DH, Kim H, Lee* W, Chae HK, Lee J, Choi W, You D, Jeong IG, Hong JH, Ahn H, Kim C. MP09-08 PERCENT TUMOR VOLUME VS. THE SUBCLASSIFICATION OF AMERICAN JOINT COMMITTEE ON CANCER STAGING SYSTEM ON PREDICTION OF BIOCHEMICAL RECURRENCE IN PATIENTS WITH PATHOLOGIC T2 PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.JU.0000555132.31025.a2 |
0.315 |
|
| 2018 |
Choi SY, Ryu J, You D, Hong JH, Ahn H, Kim CS. Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification. International Journal of Urology : Official Journal of the Japanese Urological Association. PMID 30238513 DOI: 10.1111/iju.13800 |
0.333 |
|
| 2018 |
Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C. Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data. Prostate Cancer and Prostatic Diseases. PMID 30214035 DOI: 10.1038/s41391-018-0088-z |
0.32 |
|
| 2018 |
Kim JK, Choi MJ, Lee JS, Hong JH, Kim CS, Seo SI, Jeong CW, Byun SS, Koo KC, Chung BH, Park YH, Lee JY, Choi IY. A Deep Belief Network and Dempster-Shafer-Based Multiclassifier for the Pathology Stage of Prostate Cancer. Journal of Healthcare Engineering. 2018: 4651582. PMID 29755715 DOI: 10.1155/2018/4651582 |
0.342 |
|
| 2018 |
Kim M, Song C, Jeong IG, Choi SK, Park M, Shim M, Kim YS, You D, Hong JH, Kim CS, Ahn H. Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study. Bmc Cancer. 18: 271. PMID 29523103 DOI: 10.1186/s12885-018-4189-9 |
0.349 |
|
| 2018 |
Choi SY, Ryu J, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study. Journal of Cancer Research and Clinical Oncology. PMID 29417257 DOI: 10.1007/s00432-018-2597-5 |
0.366 |
|
| 2018 |
Nam W, Choi SY, Yoo SJ, Ryu J, Lee J, Kyung YS, Han JH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer. Investigative and Clinical Urology. 59: 18-24. PMID 29333510 DOI: 10.4111/icu.2018.59.1.18 |
0.333 |
|
| 2018 |
Yu SH, Choi MJ, Kim C, Seo SI, Jeong CW, Byun S, Lee JY, Hong JH, Choi IY. Comparison of Surgical Outcomes of Radical Prostatectomy Using the Multicenter Korean Prostate Cancer Registry (KPCR) Database Journal of Health Informatics and Statistics. 43: 175-183. DOI: 10.21032/jhis.2018.43.3.175 |
0.322 |
|
| 2018 |
Ryu J, Choi S, Lee J, Lee W, Chae H, Choi W, Kyung Y, Park S, Moon K, You D, Jeong I, Hong J, Ahn H, Kim C. Differences of oncologic outcomes of prostate cancer with nodal metastasis in the absence of distant metastasis according to initial treatment: Radical prostatectomy vs. androgen deprivation therapy European Urology Supplements. 17: e1168. DOI: 10.1016/S1569-9056(18)31654-3 |
0.331 |
|
| 2018 |
Choi S, Ryu J, Lee J, Lee W, Chae H, Choi W, Kyung Y, Park S, Moon K, You D, Jeong I, Hong J, Ahn H, Kim C, Han J. Androgen deprivation therapy should not be used as monotherapy in high or very high risk localized prostate cancer European Urology Supplements. 17: e1165. DOI: 10.1016/S1569-9056(18)31651-8 |
0.302 |
|
| 2018 |
Nam W, Choi S, Ryu J, Kyung Y, Moon K, Park S, Chae H, Lee W, Lee J, Han J, Choi W, You D, Jeong I, Hong J, Ahn H, et al. Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer European Urology Supplements. 17: e1078. DOI: 10.1016/s1569-9056(18)31584-7 |
0.331 |
|
| 2018 |
Choi S, Ryu J, Lee J, Lee W, Chae H, Choi W, Kyung Y, Park S, Moon K, You D, Jeong I, Hong J, Ahn H, Kim C. Prognostic factors for oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate cancer with enzalutamide European Urology Supplements. 17: e884-e885. DOI: 10.1016/s1569-9056(18)31450-7 |
0.309 |
|
| 2018 |
Nam W, Choi SY, Ryu J, Kyung YS, Moon KH, Park S, Chae HK, Lee W, Lee J, Choi W, You D, Jeong IG, Hong JH, Ahn H, Kim C. MP87-17 FACTORS ASSOCIATED WITH TESTOSTERONE RECOVERY AFTER ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER Journal of Urology. 199. DOI: 10.1016/j.juro.2018.02.2917 |
0.332 |
|
| 2017 |
Yoo S, You D, Kim YS, Hong JH, Ahn H, Kim CS. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy. Urologia Internationalis. PMID 29020683 DOI: 10.1159/000481265 |
0.34 |
|
| 2017 |
Koo KC, Lee KS, Jeong JY, Choi IY, Lee JY, Hong JH, Kim CS, Lee HM, Hong SK, Byun SS, Lee SH, Rha KH, Chung BH. Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry. Japanese Journal of Clinical Oncology. 47: 981-985. PMID 28981735 DOI: 10.1093/jjco/hyx101 |
0.331 |
|
| 2017 |
Yoo S, Hong JH, Byun SS, Lee JY, Chung BH, Kim CS. Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry. Urologic Oncology. PMID 28476529 DOI: 10.1016/j.urolonc.2016.07.014 |
0.303 |
|
| 2017 |
Lee KS, Koo KC, Choi IY, Lee JY, Hong JH, Kim CS, Lee HM, Hong SK, Byun SS, Rha KH, Chung BH. Re-Stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines Among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 28279067 DOI: 10.4143/crt.2016.494 |
0.331 |
|
| 2016 |
Kim M, Choi SK, Park M, Shim M, Song C, Jeong IG, Hong JH, Kim CS, Ahn H. Characteristics of anteriorly located prostate cancer and the usefulness of multiparametric magnetic resonance imaging for its diagnosis. The Journal of Urology. PMID 26997311 DOI: 10.1016/j.juro.2016.03.075 |
0.473 |
|
| 2015 |
Park J, Suh B, Shin DW, Hong JH, Ahn H. Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 26511804 DOI: 10.4143/crt.2015.212 |
0.303 |
|
| 2015 |
Jung J, Lee C, Lee C, Kwon T, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer. Korean Journal of Urology. 56: 630-6. PMID 26366275 DOI: 10.4111/kju.2015.56.9.630 |
0.332 |
|
| 2015 |
Jeong IG, Dajani D, Verghese M, Hwang J, Cho YM, Hong JH, Kim CS, Ahn H, Ro JY. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy. Urologic Oncology. PMID 26345648 DOI: 10.1016/j.urolonc.2015.08.004 |
0.325 |
|
| 2015 |
Lee D, Lee C, Kwon T, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia. Korean Journal of Urology. 56: 565-71. PMID 26279825 DOI: 10.4111/kju.2015.56.8.565 |
0.327 |
|
| 2015 |
Kwon T, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate. Korean Journal of Urology. 56: 288-94. PMID 25874042 DOI: 10.4111/kju.2015.56.4.288 |
0.37 |
|
| 2015 |
Kim A, Kwon T, You D, Jeong IG, Go H, Cho YM, Hong JH, Ahn H, Kim CS. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma. Journal of Korean Medical Science. 30: 385-9. PMID 25829805 DOI: 10.3346/jkms.2015.30.4.385 |
0.304 |
|
| 2015 |
Choi SK, Song C, Shim M, Min GE, Park J, Jeong IG, Hong JH, Kim CS, Ahn H. Prevalence of high-grade or insignificant prostate cancer in Korean men with prostate-specific antigen levels of 3.0-4.0 ng/mL. Urology. 85: 610-5. PMID 25586476 DOI: 10.1016/j.urology.2014.11.012 |
0.487 |
|
| 2015 |
Song C, Park S, Park J, Shim M, Kim A, Jeong IG, Hong JH, Kim CS, Ahn H. Statin use after radical prostatectomy reduces biochemical recurrence in men with prostate cancer. The Prostate. 75: 211-7. PMID 25327522 DOI: 10.1002/pros.22907 |
0.353 |
|
| 2015 |
Yoo S, Lee C, Sohn M, Lee C, Hong S, Kim HJ, Song SH, Kim KS, You D, Kwon T, Jeong IG, Park S, Moon KH, Hong JH, Ahn H, et al. MP78-02 RELATIONSHIP BETWEEN THE CONTINUITY AND DISCONTINUITY OF TWO POSITIVE CORES IN PROSTATE BIOPSY SPECIMENS FOR THE PREDICTION OF LOW-RISK PROSTATE CANCER AND IDENTIFICATION OF CANDIDATES FOR ACTIVE SURVEILLANCE Journal of Urology. 193. DOI: 10.1016/j.juro.2015.02.2818 |
0.334 |
|
| 2014 |
Sohn M, Kwon T, Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS. Histologic variability and diverse oncologic outcomes of prostate sarcomas. Korean Journal of Urology. 55: 797-801. PMID 25512813 DOI: 10.4111/kju.2014.55.12.797 |
0.326 |
|
| 2014 |
Hong S, Kim SC, Kwon T, Jeong IG, Kim CS, Ahn H, Hong JH. Is bladder tumor location associated with prostate cancer detection after intravesical bacillus Calmette-Guérin instillation? Plos One. 9: e103791. PMID 25072158 DOI: 10.1371/journal.pone.0103791 |
0.325 |
|
| 2014 |
Lim JH, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prognosis of prostate cancer with other primary malignancies. Korean Journal of Urology. 55: 327-34. PMID 24868337 DOI: 10.4111/kju.2014.55.5.327 |
0.364 |
|
| 2014 |
Hong JH, Kim IY. Nonmetastatic castration-resistant prostate cancer. Korean Journal of Urology. 55: 153-60. PMID 24648868 DOI: 10.4111/kju.2014.55.3.153 |
0.345 |
|
| 2014 |
Kwon T, Jeong IG, Park M, You D, Lee J, Kim HK, Hong S, Hong JH, Ahn H, Kim CS. Bone mineral density in prostate cancer: a comparative study of patients with prostate cancer and healthy controls using propensity score matching. Urology. 83: 385-92. PMID 24269223 DOI: 10.1016/j.urology.2013.08.045 |
0.328 |
|
| 2014 |
You D, Jeong IG, Song C, Cho YM, Hong JH, Kim CS, Ahn H. High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin. International Journal of Urology : Official Journal of the Japanese Urological Association. 21: 484-9. PMID 24256352 DOI: 10.1111/iju.12348 |
0.321 |
|
| 2014 |
Han K, Kwon T, Jeong IG, You D, Lim B, Lee D, Lee C, Hong S, Kim H, Hwang JJ, Hong JH, Choo M, Ahn TY, Kim C. MP52-14 SYNERGISTIC EFFECTS OF COMBINATION OF DOCETAXEL AND SAHA ON AR SIGNALING IN PROSTATE CANCER Journal of Urology. 191. DOI: 10.1016/j.juro.2014.02.1624 |
0.317 |
|
| 2013 |
Kim Y, Ahn JH, Choi M, Hong SW, Jeong IG, Song C, Hong BS, Hong JH, Kim CS, Ahn H. Activity of gemcitabine-oxalipaltin (GemOx) plus prednisolone in patients with castration-resistant prostate cancer (CRPC) for whom docetaxel-based chemotherapy failed. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 108. PMID 28136992 DOI: 10.1200/jco.2013.31.6_suppl.108 |
0.342 |
|
| 2013 |
Song G, Lee C, You D, Jeong IG, Hong JH, Ahn H, Kim CS. Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice. Prostate International. 1: 125-32. PMID 24223414 DOI: 10.12954/PI.13024 |
0.318 |
|
| 2013 |
Jeong IG, Lim JH, Hwang SS, Kim SC, You D, Hong JH, Ahn H, Kim CS. Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy. Prostate International. 1: 69-75. PMID 24223405 DOI: 10.12954/PI.12008 |
0.308 |
|
| 2013 |
Araujo JC, Trudel GC, Saad F, Armstrong AJ, Yu EY, Bellmunt J, Wilding G, McCaffrey J, Serrano SV, Matveev VB, Efstathiou E, Oudard S, Morris MJ, Sizer B, Goebell PJ, ... ... Hong JH, et al. Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial. The Lancet. Oncology. 14: 1307-16. PMID 24211163 DOI: 10.1016/S1470-2045(13)70479-0 |
0.305 |
|
| 2013 |
Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, Cho KS, Hong JH, Ahn H, Kim CS. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies. The Journal of Urology. 190: 2054-60. PMID 23791890 DOI: 10.1016/j.juro.2013.06.035 |
0.319 |
|
| 2013 |
Song C, Kang T, Yoo S, Jeong IG, Ro JY, Hong JH, Kim CS, Ahn H. Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancer Urologic Oncology: Seminars and Original Investigations. 31: 168-174. PMID 21719325 DOI: 10.1016/j.urolonc.2010.11.005 |
0.315 |
|
| 2013 |
Song G, Moon KH, Joung JY, You D, Jeong IG, Hong JH, Kim C, Ahn TY. 2056 THE EFFECT OF 5¥Á-REDUCTASE INHIBITOR ON CLINICOPATHOLOGIC CHARACTERISTICS OF PROSTATE CANCER IN PATIENT WHO UNDERGO RADICAL PROSTATECTOMY Journal of Urology. 189. DOI: 10.1016/J.JURO.2013.02.2475 |
0.353 |
|
| 2012 |
Kim D, Choi D, Lim JH, Yoon JH, Jeong IG, You D, Hong JH, Ahn H, Kim CS. Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea. Korean Journal of Urology. 53: 680-5. PMID 23136627 DOI: 10.4111/kju.2012.53.10.680 |
0.353 |
|
| 2012 |
Park M, You D, Yoon JH, Jeong IG, Song C, Hong JH, Ahn H, Kim CS. Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy. Bju International. 109: 1474-9. PMID 21933324 DOI: 10.1111/j.1464-410X.2011.10442.x |
0.363 |
|
| 2011 |
Lim J, Yoo D, You D, Kim Y, Jeong I, Hong B, Hong J, Ahn H, Ahn T, Kim C. UP-02.100 Antitumor Effect of Sodium Metaarsenite on the Prostate Cancer Cell and Its Mechanism Urology. 78: S294. DOI: 10.1016/J.UROLOGY.2011.07.918 |
0.338 |
|
| 2010 |
Kim SC, Jeong I, Song C, Hong JH, Kim CS, Ahn H. Biochemical recurrence-free and cancer-specific survival after radical prostatectomy at a single institution. Korean Journal of Urology. 51: 836-42. PMID 21221203 DOI: 10.4111/kju.2010.51.12.836 |
0.307 |
|
| 2010 |
Jeong IG, Kim JK, Cho KS, You D, Song C, Hong JH, Ahn H, Kim CS. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy. The Journal of Urology. 184: 1963-9. PMID 20851437 DOI: 10.1016/j.juro.2010.06.136 |
0.357 |
|
| 2010 |
Yoon CJ, Song HY, Kim JH, Park HG, Kang HS, Ro JY, Hong JH. Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates. Journal of Vascular and Interventional Radiology : Jvir. 21: 1429-35. PMID 20688535 DOI: 10.1016/j.jvir.2010.05.013 |
0.303 |
|
| 2010 |
Park J, Jeong IG, Bang JK, Cho YM, Ro JY, Hong JH, Ahn H, Kim CS. Preoperative Clinical and Pathological Characteristics of pT0 Prostate Cancer in Radical Prostatectomy. Korean Journal of Urology. 51: 386-90. PMID 20577604 DOI: 10.4111/kju.2010.51.6.386 |
0.337 |
|
| 2010 |
Kwon T, Jeong IG, You D, Park MC, Hong JH, Ahn H, Kim CS. Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level? Bju International. 106: 633-8. PMID 20067448 DOI: 10.1111/j.1464-410X.2009.09182.x |
0.35 |
|
| 2010 |
Kang T, Kim W, Lee J, Song C, Hong JH, Kim C, Ahn H. 586 SURGICAL OUTCOMES OF NEOADJUVANT DOCETAXEL CHEMOTHERAPY COMPARED WITH RADICAL PROSTATECTOMY ALONE IN PATIENTS WITH HIGH RISK PROSTATE CANCER Journal of Urology. 183. DOI: 10.1016/j.juro.2010.02.858 |
0.324 |
|
| 2010 |
Kang T, Park S, Song C, Hong JH, Kim C, Ahn H. 2099 PREDICTORS OF PROSTATE CANCER DETECTION ON REPEAT BIOPSY IN MEN WITH AN ATYPICAL SMALL ACINAR PROLIFERATION ON INITIAL PROSTATE BIOPSY Journal of Urology. 183. DOI: 10.1016/j.juro.2010.02.2173 |
0.347 |
|
| 2009 |
Kwon T, Jeong IG, Hong JH, Ahn H, Kim C. Analysis of the Clinicopathologic Characteristics of Men with Prostate Cancer Undergoing Radical Prostatectomy in the Prostate-Specific Antigen Range of Less than 4 ng/ml Korean Journal of Urology. 50: 320. DOI: 10.4111/KJU.2009.50.4.320 |
0.35 |
|
| 2009 |
You D, Park J, Jeong I, Park C, Park J, Cheon S, Hong J, Park N, Ahn H, Kim C. MP-16.09: Preoperative Clinical and Pathological Characteristics of Pt0 Prostate Cancer in Radical Prostatectomy Urology. 74: S122. DOI: 10.1016/j.urology.2009.07.823 |
0.328 |
|
| 2009 |
Park J, Jeong I, Park C, Park J, Cheon S, Hong J, Park H, Ahn H, Kim C, You D. UP-2.151: Impact of Prostate Volume on Pathologic Outcome and Biochemical Recurrence in Prostate Cancer After Radical Prostatectomy: Is It Correlated with Serum Testosterone? Urology. 74: S279. DOI: 10.1016/j.urology.2009.07.370 |
0.346 |
|
| 2008 |
Watson J, Hong JH, Lee GT, Kim IY. OVEREXPRESSION OF BMP-6 IN PROSTATE CANCER CELLS LEADS TO AN ENHANCED TUMORIGENESIS IN VIVO BY INHIBITING MACROPHAGES Journal of Urology. 179: 458-458. DOI: 10.1016/S0022-5347(08)61345-2 |
0.313 |
|
| 2006 |
Song C, Kang T, Shin GH, Shin D, Ro JY, Hong J, Kim C, Ahn H. 264: Anatomic Distribution and Pathological Characteristics of Prostate Cancer in Korean Men: A Mapping Analysis Journal of Urology. 175: 88-88. DOI: 10.1016/s0022-5347(18)32531-x |
0.302 |
|
| Show low-probability matches. |